Annual report pursuant to Section 13 and 15(d)

OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)

v3.22.1
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
12 Months Ended
Dec. 31, 2021
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table presents information related to stock options at December 31, 2021:

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Exercisable

 

 

Exercise

 

 

Number of

 

 

Remaining Life

 

 

Number of

 

 

Price

 

 

Options

 

 

In Years

 

 

Options

 

 

$

Under 3.00

 

 

 

1,035,375

 

 

 

9.5

 

 

 

560,000

 

 

 

3.00-3.99

 

 

 

587,466

 

 

 

6.5

 

 

 

387,466

 

   

4.00-4.99

     

1,762,916

     

6.2

     

1,151,545

 
   

5.00-5.99

     

156,132

     

7.1

     

119,464

 
   

6.00-6.99

     

591,542

     

5.0

     

478,846

 

 

 

7.00-7.99

 

 

 

191,720

 

 

 

6.9

 

 

 

177,138

 

 

 

Over 8.00

 

 

 

243,333

 

 

 

6.3

 

 

 

197,351

 

 

 

 

 

 

 

4,568,484

 

 

 

6.9

 

 

 

3,071,810

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Exercisable

 

Exercise

 

 

Number of

 

 

Remaining Life

 

 

Number of

 

Price

 

 

Options

 

 

In Years

 

 

Options

 

$

5.00

 

 

 

125,000

 

 

 

7.2

 

 

 

83,331

 

 

Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the Plan for the two years ended December 31, 2021 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at January 1, 2020

    3,980,804     $ 5.58       6.3     $ 3,130,791  

Grants

    1,120,000     $ 4.98       10.0       -  

Exercised

    (1,203,223

)

  $ 5.08                  

Forfeited/expired

    (329,084

)

  $ 5.19                  

Outstanding at December 31, 2020

    3,568,497     $ 5.59       7.0     $ 110,961  

Grants

    1,818,000     $ 3.69       10.0     $ -  

Exercised

    (9,375

)

  $ 2.96                  

Forfeited/expired

    (808,638

)

  $ 6.19                  

Outstanding at December 31, 2021

    4,568,484     $ 4.57       6.9     $ -  

Exercisable at December 31, 2021

    3,071,810     $ 4.83       6.0     $ -  

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following assumptions were used in determining the fair value of options during the years ended December 31, 2021 and 2020:

 

   

2021

   

2020

 

Risk-free interest rate

    0.77% - 1.49

%

    0.42% to 1.83

%

Dividend yield

    0

%

    0

%

Stock price volatility

    82.50% to 95.98

%

    86.51% to 93.43

%

Expected life

 

5 – 10 years

   

5-10 years

 

Weighted average grant date fair value

  $ 2.55     $ 4.03  

 

Risk-free interest rate

    0.05% - 0.25

%

Dividend yield

    0

%

Stock price volatility

    88.57

%

Expected life

 

0.25 – 2 years

 

 

Risk-free interest rate

    0.06% - 0.46

%

Dividend yield

    0

%

Stock price volatility

    88.59

%

Expected life

 

0.59 – 3 years

 

 

Risk-free interest rate

    0.36% to 0.52

%

Dividend yield

    0

%

Stock price volatility

    125.16% to 126.03

%

Expected life

 

5 – 6 years

 

Weighted average grant date fair value

  $ 4.51  

 

Risk-free interest rate

    0.07% - 0.46

%

Dividend yield

    0

%

Stock price volatility

    88.59

%

Expected life

 

1.25 - 3 years

 

 

Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block]

The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at December 31, 2021:

 

 

Exercise

 

 

Number

 

Expiration

 

Price

 

 

Outstanding

 

Date

 

$

4.80

 

 

 

250,000

 

February 2025 to July 2026

 

$

6.16

 

 

 

568,910

 

November 2027

 

 

 

 

 

 

818,910

 

 

 

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of the warrant activity for the two years ended December 31, 2021 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at January 1, 2020

    2,744,718     $ 5.40       2.2     $ 3,410,763  

Issued

    125,000     $ 4.80       4.2       -  

Exercised

    (580,487

)

  $ 3.89                  

Expired

    (843,031

)

  $ 6.29                  

Outstanding at December 31, 2020

    1,446,200     $ 5.44       3.3     $ 1,500  

Issued

    125,000     $ 4.80       5.0          

Expired

    (752,290

)

  $ 5.00       -       -  

Outstanding at December 31, 2021

    818,910     $ 5.74       5.3     $ -  
                                 

Vested and expected to vest at December 31, 2021

    818,910     $ 5.74       5.3     $ -  

Exercisable at December 31, 2021

    818,910     $ 5.74       5.3     $ -  

 

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes the restricted stock activity for the two years ended December 31, 2021:

 

Restricted shares issued as of January 1, 2020

    262,668  

Granted

    175,000  

Vested and issued

    (219,334

)

Restricted shares issued as of December 31, 2020

    218,334  

Granted

    301,000  

Vested and issued

    (258,084

)

Forfeited

    (120,000

)

Vested restricted shares as of December 31, 2021

    -  

Unvested restricted shares as of December 31, 2021

    141,250  

 

Restricted shares outstanding at January 1, 2020:

    40,000  

Granted

    1,380,716  

Restricted shares outstanding at December 31, 2020:

    1,420,716  

Issued

    (40,000

)

Forfeited

    (62,037

)

Total restricted shares outstanding at December 31, 2021:

    1,318,679  
         

Comprised of:

       

Vested restricted shares as of December 31, 2021

    678,679  

Unvested restricted shares as of December 31, 2021

    640,000  

Total

    1,318,679  

 

Schedule of Warrants or Rights, Shares Authorized, Exercise Price Range [Table Text Block]

The following table presents information related to warrants (ViralClear) at December 31, 2021:

 

 

Exercise

 

 

Number

 

Expiration

 

Price

 

 

Outstanding

 

Date

 

$

5.00

 

 

 

473,772

 

November 2027

 

 

10.00

 

 

 

6,575

 

May 2025

 

 

 

 

 

 

480,347

 

 

 

Viral Clear [Member]  
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the ViralClear Plan for the two years ended December 31, 2021 is as follows:

 

                   

Weighted-Average

 
           

Weighted-Average

   

Remaining

 
   

Shares

   

Exercise Price

   

Contractual Term

 

Outstanding at January 1, 2020

    575,000     $ 5.00       9.3  

Grants

    1,599,173     $ 5.31       9.6  

Forfeited/expired

    (646,507

)

  $ 5.77          

Outstanding at December 31, 2020

    1,527,666     $ 5.00       4.0  

Exercised

    (550,000

)

  $ 5.00          

Forfeited/expired

    (852,666

)

  $ 5.00          

Outstanding at December 31, 2021

    125,000     $ 5.00       7.2  

Exercisable at December 31, 2021

    83,331     $ 5.00       6.6